The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2012
Arabin cerclage pessary in the management of cervical insufficiency.
Оценочное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ting Yuen Ha, Lao Terence T, Wa Law Lai, Hui Shuk Yi Annie, Chor Chung Ming, Lau Tze Kin, Yeung Leung Tak
Аннотация
OBJECTIVE: To evaluate the use of Arabin cerclage pessary in the management of cervical insufficiency.
METHODS: The pregnancy outcome of 20 women carrying singleton pregnancy referred for suspected cervical insufficiency and chose Arabin cerclage pessary for treatment from 2009-2011 were reviewed. Pregnancy outcome were analysed according to presence of risk factors, amniotic fluid sludge, cervical length and gestation at pessary insertion.
RESULTS: At presentation, mean cervical length was 1.17 cm (range 0-2.33 cm), mean gestation at pessary insertion and delivery was 20.6 (12.9-26.1) weeks and 32.1 (14.7-40.1) weeks, respectively, and mean prolongation of pregnancy was 11.5 (0.5-25.2) weeks. Overall, 5 (25%) had fetal loss between 14.7-23.1 weeks, while 3 (15%) and 12 (60%) delivered before and after 34 weeks gestation, respectively with no perinatal mortality. Compared with women with cervical length <1.5 cm, all those with cervical length ≥1.5 cm had pregnancy prolonged for ≥49 days (100 vs. 54% p = 0.032) and 86% delivered beyond 34 weeks (86 vs. 46% p = 0.085).
CONCLUSIONS: Arabin cerclage pessary appears to be optimal for treating women at high risk of cervical insufficiency with a cervical length of 1.5-2.5 cm, while it is an acceptable option for high risk women with cervical length <1.5 cm.
METHODS: The pregnancy outcome of 20 women carrying singleton pregnancy referred for suspected cervical insufficiency and chose Arabin cerclage pessary for treatment from 2009-2011 were reviewed. Pregnancy outcome were analysed according to presence of risk factors, amniotic fluid sludge, cervical length and gestation at pessary insertion.
RESULTS: At presentation, mean cervical length was 1.17 cm (range 0-2.33 cm), mean gestation at pessary insertion and delivery was 20.6 (12.9-26.1) weeks and 32.1 (14.7-40.1) weeks, respectively, and mean prolongation of pregnancy was 11.5 (0.5-25.2) weeks. Overall, 5 (25%) had fetal loss between 14.7-23.1 weeks, while 3 (15%) and 12 (60%) delivered before and after 34 weeks gestation, respectively with no perinatal mortality. Compared with women with cervical length <1.5 cm, all those with cervical length ≥1.5 cm had pregnancy prolonged for ≥49 days (100 vs. 54% p = 0.032) and 86% delivered beyond 34 weeks (86 vs. 46% p = 0.085).
CONCLUSIONS: Arabin cerclage pessary appears to be optimal for treating women at high risk of cervical insufficiency with a cervical length of 1.5-2.5 cm, while it is an acceptable option for high risk women with cervical length <1.5 cm.